Map: Deaths from rheumatic heart disease
Mortality and burden of disease estimates for countries provided by Colin Mathers (Evidence and Information for Policy, WHO) from analyses prepared for The World Health Report 2003.
Carapetis JR. The current evidence for the burden of group A streptococcal diseases. A review of WHO activities in, the burden of, and the evidence for strategies to control group A streptococcal diseases. Geneva,
Deaths from rheumatic fever and rheumatic heart disease in the Aboriginal and non-
Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in Aboriginal people. Australian and New Zealand journal of public health, 1999, 23:159-163.
Rheumatic fever and rheumatic heart disease: report of a WHO Expert Committee. Geneva, WHO, 2003 (WHO Technical Report Series, No. 923).
Stollerman GH. Rheumatic fever in the 21st century. Clinics in infectious diseases, 2001, 33:806—814.
Treating acute rheumatic fever. British medical journal, 2003, 327:631-63 (editorial).
WHO. The World Health Report 2003: shaping the future. Geneva, WHO, 2003, Annex Table 2:156.
Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatric infectious diseases journal, 1997, 16:400-407.
PART 2 RISK FACTORS
Was this article helpful?